Dr. Artenie's research focuses primarily on the epidemiology and prevention of hepatitis C, HIV, overdoses, and other harms related to drug use among people who inject drugs, as well as other vulnerable populations (e.g., men who have sex with men, sex workers). Her research program combines several complementary methodologies, including mathematical modeling, analysis of longitudinal databases, and systematic reviews. Her work is strongly oriented toward public health policy and has notably contributed to the development of WHO guidelines on the elimination of hepatitis C.

Dr. Adelina Artenie holds a Master’s degree in Experimental Medicine (specializing in Epidemiology) from McGill University and a PhD in Public Health and Epidemiology from the School of Public Health at the Université de Montréal. After completing her PhD, she pursued postdoctoral training focused on mathematical modeling of infectious diseases in vulnerable populations at the University of Bristol in England. Throughout her training, Adelina was awarded competitive scholarships to support her research projects, including funding from CIHR, FRQS, and the Canadian Network on Hepatitis C.

I am able to supervise new research students at the master’s, doctoral, and postdoctoral levels.

Étudiants au doctorat

1. Belinda Njiro
   • Diplôme: en cours
   • Années: 2024 – présent
   • Titre mémoire: Prevalence of stigma, discrimination and violence among people who inject drugs globally and their impact on HIV and hepatitis C infection
   • Rôle: Co-superviseur 
2. Harika Dasari
   • Diplôme: en cours
   • Années: 2023 – présent
   • Titre mémoire: Characterising mortality trends among people who inject drugs and the impact of homelessness on mortality
   • Rôle: Co-superviseur 
3. Khadimul Mazhar
   • Diplôme: en cours
   • Années: 2023 – présent
   • Titre mémoire: Characterising HIV incidence and associated factors among people who inject drugs in low- and middle-income countries
   • Rôle: Co-superviseur 
4. Joshua Dawe 
   • Diplôme: en cours
   • Années: 2022 – présent
   • Titre mémoire: Homelessness and elimination of HIV and hepatitis C virus (HCV) in people who inject drugs: Building evidence for better action
   • Rôle: Co-superviseur 

Étudiants à la maîtrise 

1. Huishan Yan
   • Diplôme: obtenu
   • Année: 2024
   • Titre mémoire: Characterising HIV, Hepatitis C virus (HCV) and hepatitis B virus (HBV) incidence among people who inject drugs in the country of Georgia
   • Rôle: Superviseur
2. Megan Minett-Smith
   • Diplôme: obtenu
   • Année: 2024
   • Titre mémoire: Trends in benzodiazepine use and the association with non-fatal overdose among people who inject opioids in England, Wales and Northern Ireland
   • Rôle: Superviseur
3. Kenzie Nicks
   • Diplôme: obtenu
   • Année: 2023
   • Titre mémoire: Scoping ambulance service data to characterise non-fatal overdose in Bristol, North Somerset and South Gloucestershire
   • Rôle: Superviseur
4. Rachel Perry
   • Diplôme: obtenu
   • Année: 2022
   • Titre mémoire: Estimating HIV incidence and associated risk factors among people who inject drugs in South Africa
   • Rôle: Superviseur
5. Vishal Singh
   • Diplôme: obtenu
   • Année: 2021
   • Titre mémoire: Injection frequency and the association with incident hepatitis C virus infection among people who inject drugs: A systematic review
   • Rôle: Superviseur
6. Christiane Spring
   • Diplôme: obtenu
   • Année: 2021
   • Titre mémoire: Characterising naloxone access and carriage among people who inject drugs in the UK
   • Rôle: Superviseur

Artenie A, Trickey A, Looker KJ, Stone J, Lim AG, Fraser H, Degenhardt L, Dore GJ, Grebely J, Cunningham EB, Hajarizadeh B, Low-Beer D, Luhmann N, Webb P, Hickman M, Vickerman P. Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis. Lancet Gastroenterol Hepatol, April 2025; DOI: 10.1016/S2468-1253(24)00442-4; PubMed: 39993400.

Artenie A, Perry R, Mahaso M, Jankie T, McNaughton AL, Stone J, Vickerman P, Scheibe A. HIV incidence and factors associated with HIV risk among people who inject drugs engaged with harm-reduction programmes in four provinces in South Africa: a retrospective cohort study. Lancet HIV, December 2024; DOI: 10.1016/S2352-3018(24)00263-7; PubMed: 39632050.

Stannah J, Flores Anato JL, Pickles M, Larmarange J, Mitchell KM, Artenie A, Dumchev K, Niangoran S, Platt L, Terris-Prestholt F, Singh A, Stone J, Vickerman P, Phillips A, Johnson L, Maheu-Giroux M, Boily MC. From conceptualising to modelling structural determinants and interventions in HIV transmission dynamics models: a scoping review and methodological framework for evidence-based analyses. BMC Med, September 19, 2024; DOI: 10.1186/s12916-024-03580-z; PubMed: 39300441.

Stevens A, Keemink JR, Shirley-Beavan S, Khadjesari Z, Artenie A, Vickerman P, Southwell M, Shorter GW. Overdose prevention centres as spaces of safety, trust and inclusion: A causal pathway based on a realist review. Drug Alcohol Rev, September 2024; DOI: 10.1111/dar.13908; PubMed: 39104059.

Fraser H, Stone J, Facente SN, Artenie A, Patel S, Wilson EC, McFarland W, Page K, Vickerman P, Morris MD. Modeling the impact of the COVID-19 pandemic on achieving HCV elimination amongst young and unstably housed people who inject drugs in San Francisco. Int J Drug Policy, September 2024; DOI: 10.1016/j.drugpo.2024.104452; PubMed: 38910096.

Levinsson A, Zolopa C, Vakili F, Udhesister S, Kronfli N, Maheu-Giroux M, Bruneau J, Valerio H, Bajis S, Read P, Martró E, Boucher L, Morris L, Grebely J, Artenie A, Stone J, Vickerman P, Larney S. Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis. EClinicalMedicine, April 10, 2024; DOI: 10.1016/j.eclinm.2024.102596; PubMed: 38633576.

Artenie A, Stone J, Facente SN, Fraser H, Hecht J, Rhodes P, McFarland W, Wilson E, Hickman M, Vickerman P, Morris MD. Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling Analysis. J Infect Dis, September 15, 2023; DOI: 10.1093/infdis/jiad169; PubMed: 37486337.

Artenie A, Stone J, Fraser H, Stewart D, Arum C, Lim AG, McNaughton AL, Trickey A, Ward Z, Abramovitz D, Alary M, Astemborski J, Bruneau J, Clipman SJ, Coffin CS, Croxford S, DeBeck K, Emanuel E, Hayashi K, Hermez JG, Low-Beer D, Luhmann N, Macphail G, Maher L, Palmateer NE, Patel EU, Sacks-Davis R, Van Den Boom W, van Santen DK, Walker JG, Hickman M, Vickerman P; HIV and HCV Incidence Review Collaborative Group. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis. Lancet Gastroenterol Hepatol, June 2023; DOI: 10.1016/S2468-1253(23)00018-3; PubMed: 36996853.

Trickey A, Fajardo E, Alemu D, Artenie AA, Easterbrook P. Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol, March 2023; DOI: 10.1016/S2468-1253(22)00346-6; PubMed: 36706775.

Cheng Q, Cunningham EB, Shih S, Amin J, Bruneau J, Artenie AA, Powis J, Litwin AH, Cooper C, Dalgard O, Hellard M, Bruggmann P, Marks P, Lacombe K, Stedman C, Read P, Hajarizadeh B, Dunlop AJ, Conway B, Feld JJ, Dore GJ, Grebely J; SIMPLIFY and D3FEAT Study Groups. Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs. Value Health, June 2023; DOI: 10.1016/j.jval.2022.12.016; PubMed: 36646278.

Artenie A, Facente SN, Patel S, Stone J, Hecht J, Rhodes P 3rd, McFarland W, Wilson E, Vickerman P, Morris MD. A cross-sectional study comparing men who have sex with men and inject drugs and people who inject drugs who are men and have sex with men in San Francisco: Implications for HIV and hepatitis C virus prevention. Health Sci Rep, July 12, 2022; DOI: 10.1002/hsr2.704; PubMed: 35844825.

Spring C, Croxford S, Ward Z, Ayres R, Lord C, Desai M, Emanuel E, Vickerman P, Artenie A. Perceived availability and carriage of take-home naloxone and factors associated with carriage among people who inject drugs in England, Wales and Northern Ireland. Int J Drug Policy, April 2022; DOI: 10.1016/j.drugpo.2022.103615; PubMed: 35172254.

Artenie A, Luhmann N, Lim AG, Fraser H, Ward Z, Stone J, MacGregor L, Walker JG, Trickey A, Marquez LK, Abu-Raddad LJ, Ayoub HH, Walsh N, Hickman M, Martin NK, Easterbrook P, Vickerman P. Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHO. Lancet Gastroenterol Hepatol, April 2022; DOI: 10.1016/S2468-1253(21)00311-3; PubMed: 35122713.

Stone J, Artenie A, Hickman M, Martin NK, Degenhardt L, Fraser H, Vickerman P. The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling study. Lancet Public Health, February 2022; DOI: 10.1016/S2468-2667(21)00258-9; PubMed: 35012711.

Grebely J, Collins AB, Artenie AA, Sutherland R, Meyer JP, Barocas JA, Falade-Nwulia O, Cepeda JA, Cunningham EB, Hajarizadeh B, Lafferty L, Lazarus JV, Bonn M, Marshall AD, Treloar C. Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs. Int J Drug Policy, October 2021; DOI: 10.1016/j.drugpo.2021.103469; PubMed: 34610884.

Fortier E, Høj SB, Sylvestre MP, Artenie AA, Minoyan N, Jutras-Aswad D, Grebely J, Bruneau J. Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, Canada. Int J Drug Policy, October 2021; DOI: 10.1016/j.drugpo.2021.103439; PubMed: 34518099.

Artenie AA, Hickman M, Vickerman P, Stone J, Grebely J, Bruneau J. Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infection. Int J Drug Policy, October 2021; DOI: 10.1016/j.drugpo.2021.103419; PubMed: 34452807.

Artenie AA, Fortier E, Sylvestre MP, Høj SB, Minoyan N, Gauvin L, Jutras-Aswad D, Bruneau J. Socioeconomic stability is associated with lower injection frequency among people with distinct trajectories of injection drug use. Int J Drug Policy, August 2021; DOI: 10.1016/j.drugpo.2021.103205; PubMed: 33839598.

Arum C, Fraser H, Artenie AA, Bivegete S, Trickey A, Alary M, Astemborski J, Iversen J, Lim AG, MacGregor L, Morris M, Ong JJ, Platt L, Sack-Davis R, van Santen DK, Solomon SS, Sypsa V, Valencia J, Van Den Boom W, Walker JG, Ward Z, Stone J, Vickerman P; Homelessness, HIV, and HCV Review Collaborative Group. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Public Health, May 2021; DOI: 10.1016/S2468-2667(21)00013-X; PubMed: 33780656.

Lanièce Delaunay C, Greenwald ZR, Minoyan N, Artenie AA, Jeong D, Marathe G, Saeed YA, Kolla G, Kunden RD, Okwor CIA, Wallace HL, Mendlowitz A, Liu CH, Mazouz S, D’souza S, Perciani CT, Rheault M, Palmer MA, Palayew A, Abdelnabi MN, Cunningham EB. Striving toward hepatitis C elimination in the era of COVID-19. Can Liver J, February 24, 2021; DOI: 10.3138/canlivj-2020-0027; PubMed: 35991473.

Minoyan N, Artenie AA, Zang G, Jutras-Aswad D, Turcotte MÈ, Bruneau J. Harm Reduction Coverage and Hepatitis C Incidence: Findings From a Cohort of People Who Inject Drugs. Am J Prev Med, June 2020; DOI: 10.1016/j.amepre.2020.01.024; PubMed: 32444003.

Fortier E, Sylvestre MP, Artenie AA, Minoyan N, Jutras-Aswad D, Roy É, Grebely J, Bruneau J. Associations between housing stability and injecting frequency fluctuations: findings from a cohort of people who inject drugs in Montréal, Canada. Drug Alcohol Depend, January 1, 2020; DOI: 10.1016/j.drugalcdep.2019.107744; PubMed: 31785537.

Artenie AA, Bruneau J. The authors respond to “Opioid agonist dosage adequacy from clinical and patient perspectives: further considerations”. CMAJ, September 30, 2019; DOI: 10.1503/cmaj.73208; PubMed: 31570550.

Jacka B, Roy É, Høj S, Minoyan N, Artenie AA, Zang G, Jutras-Aswad D, Bruneau J. Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada. J Viral Hepat, December 2019; DOI: 10.1111/jvh.13194; PubMed: 31433888.

Artenie AA, Cunningham EB, Dore GJ, Conway B, Dalgard O, Powis J, Bruggmann P, Hellard M, Cooper C, Read P, Feld JJ, Hajarizadeh B, Amin J, Lacombe K, Stedman C, Litwin AH, Marks P, Matthews GV, Quiene S, Erratt A, Bruneau J, Grebely J. Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study. Clin Infect Dis, May 23, 2020; DOI: 10.1093/cid/ciz633; PubMed: 31300820.

Artenie AA, Minoyan N, Jacka B, Høj S, Jutras-Aswad D, Roy É, Gauvin L, Zang G, Bruneau J. Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs. CMAJ, April 29, 2019; DOI: 10.1503/cmaj.181506; PubMed: 31036608.

Makarenko I, Artenie A, Høj S, Minoyan N, Jacka B, Zang G, Bartlett G, Jutras-Aswad D, Martel-Laferriere V, Bruneau J. Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs? Int J Drug Policy, October 2019; DOI: 10.1016/j.drugpo.2019.04.002; PubMed: 31010749.

Høj SB, Jacka B, Minoyan N, Artenie AA, Bruneau J. Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs. Int J Drug Policy, October 2019; DOI: 10.1016/j.drugpo.2019.04.001; PubMed: 31003825.

Fortier E, Artenie AA, Zang G, Jutras-Aswad D, Roy É, Grebely J, Bruneau J. Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada. Addiction, August 2019; DOI: 10.1111/add.14632; PubMed: 30957310.

Høj SB, Minoyan N, Artenie AA, Grebely J, Bruneau J. The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges? Can Liver J, July 17, 2018; DOI: 10.3138/canlivj.1.2.003; PubMed: 35990720.

Eghtesadi M, Leroux E, Fournier-Gosselin MP, Lespérance P, Marchand L, Pim H, Artenie AA, Beaudet L, Boudreau GP. Neurostimulation for Refractory Cervicogenic Headache: A Three-Year Retrospective Study. Neuromodulation, April 2018; DOI: 10.1111/ner.12730; PubMed: 29178511.

Fournier C, Ghabrash MF, Artenie A, Roy É, Zang G, Bruneau J, Jutras-Aswad D. Association between binge drug use and suicide attempt among people who inject drugs. Subst Abus, 2018; DOI: 10.1080/08897077.2017.1389800; PubMed: 28991519.

Artenie AA, Zang G, Daniel M, Fortier E, Jutras-Aswad D, Puzhko S, Bruneau J. Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection. Int J Drug Policy, September 2017; DOI: 10.1016/j.drugpo.2017.05.033; PubMed: 28587944.

Lévesque A, Roy É, Jutras-Aswad D, Zang G, Artenie AA, Bruneau J. Examining the link between psychological distress, mental health disorders and sharing behaviors among cocaine users. Addict Behav, November 2016; DOI: 10.1016/j.addbeh.2016.06.004; PubMed: 27318949.

Artenie AA, Bruneau J, Roy É, Zang G, Lespérance F, Renaud J, Tremblay J, Jutras-Aswad D. Licit and illicit substance use among people who inject drugs and the association with subsequent suicidal attempt. Addiction, October 2015; DOI: 10.1111/add.13030; PubMed: 26119212.

Artenie AA, Roy É, Zang G, Jutras-Aswad D, Bamvita JM, Puzhko S, Daniel M, Bruneau J. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention. Int J Drug Policy, October 2015; DOI: 10.1016/j.drugpo.2015.04.013; PubMed: 26005038.

Artenie AA, Bruneau J, Zang G, Lespérance F, Renaud J, Tremblay J, Jutras-Aswad D. Associations of substance use patterns with attempted suicide among persons who inject drugs: can distinct use patterns play a role? Drug Alcohol Depend, February 1, 2015; DOI: 10.1016/j.drugalcdep.2014.11.011; PubMed: 25487226.